Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients

Circulation Journal

Volumn 73, Issue 9, 2009, Pages 1705-1710

  Kajimoto, Hidemi ^a   Nakazawa, Makoto ^b   Murasaki, Kagari ^a   Hagiwara, Nobuhisa ^a   Nakanishi, Toshio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

Author keywords

Coagulation; Congenital heart disease; Endothelium

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PADGEM PROTEIN; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX; THROMBIN ANTITHROMBIN COMPLEX III; THROMBOMODULIN; TICLOPIDINE; UNCLASSIFIED DRUG; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; ATRIOPULMONARY CONNECTION; CAVOPULMONARY CONNECTION; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FLUORESCENCE; FONTAN PROCEDURE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FONTAN PROCEDURE; HUMANS; MALE; P-SELECTIN; PEPTIDE HYDROLASES; PLATELET ACTIVATION; PROTEIN C; RISK FACTORS; THROMBOEMBOLISM; THROMBOMODULIN; UP-REGULATION; YOUNG ADULT;

EID: 69549105584     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1087     Document Type: Article

References (39)

1. Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, Hillege HL, Bom VJ, van der Meer J. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990; 336: 1087-1090.
2. Stamm C, Friehs I, Mayer JE Jr, Zurakowski D, Triedman JK, Moran AM, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001; 121: 28-41. (Pubitemid 32105320)
3. Freedom RM, Hamilton R, Yoo SJ, Mikailian H, Benson L, McCrindle B, et al. The Fontan procedure: Analysis of cohorts and late complications. Cardiol Young 2000; 10: 307-331.
4. Seipelt RG, Franke A, Vazquez-Jimenez JF, Hanrath P, von Bernuth G, Messmer BJ, et al. Thromboembolic complications after Fontan procedures: Comparison of different therapeutic approaches. Ann Thorac Surg 2002; 74: 556-562. (Pubitemid 34838867)
5. Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE. Thromboembolic complications after Fontan operations. Circulation 1995; 92(Suppl): II-287-II-293.
6. Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne EA. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 1994; 58: 1409-1414. (Pubitemid 24347534)
7. Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 2000; 119: 745-752. (Pubitemid 30395472)
8. Jacobs ML, Pourmoghadam KK, Geary EM, Reyes AT, Madan N, McGrath LB, et al. Fontan's operation: Is aspirin enough? Is coumadin too much? Ann Thorac Surg 2002; 73: 64-68. (Pubitemid 34084537)
9. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997; 113: 989-993. (Pubitemid 27271101)
10. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 1999; 82: 40-46. (Pubitemid 29309234)
11. Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kromann O, Pedersen J, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001; 85: 61-65. (Pubitemid 32973409)
12. Minamino T, Kitakaze M, Sanada S, Asanuama H, Kurotobi T, Koretsune Y, et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: Role of nitric oxide. Circulation 1998; 98: 1721-1727. (Pubitemid 28492491)
13. Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994; 28: 289-294. (Pubitemid 24131064)
14. Hrachovinova I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasia in a mouse model of hemophilia A. Nat Med 2003; 9: 1020-1025. (Pubitemid 37021781)
15. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92: 1693-1696.
16. Pongratz G, Brandt-Pohlmann M, Henneke KH, Pohle C, Zink D, Gehling G, et al. Platelet activation in embolic and preembolic states of patients with nonrheumatic atrial fibrillation. Chest 1997; 111: 929-933. (Pubitemid 27171463)
17. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524-529. (Pubitemid 36961164)
18. Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Satoh T, et al. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation 2000; 102: 2720-2725. (Pubitemid 30949249)
19. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851.
20. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries: Flow cytometric detection. Arterioscler Thromb 1992; 12: 1475-1487.
21. Ault KA, Cannon CP, Mitchell J, McCahan J, Tracy RP, Novotny WF, et al. Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial [Thrombolysis in Myocardial Infarction]. J Am Coll Cardiol 1999; 33: 634-639.
22. Goto S, Eto K, Ikeda Y, Handa S. Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shear. Lancet 1999; 353: 809. (Pubitemid 29110410)
23. Merten M, Chow T, Hellums JD, Thiagarajan P. A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000; 102: 2045-2050. (Pubitemid 30786481)
24. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595-601.
25. Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567.
26. Kajimoto H, Nakazawa M, Murasaki K, Mori Y, Tanoue K, Kasanuki H, et al. Increased thrombogenicity in patients with cyanotic congenital heart disease. Circ J 2007; 71: 948-953. (Pubitemid 46833936)
27. O'Connor CM, Gurbel PA, Serebruany VL. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol 1999; 83: 1345-1349.
28. Chung I, Choudhury A, Lip GY. Platelet activation in acute, decompensated congestive heart failure. Thromb Res 2007; 120: 709-713. (Pubitemid 47268050)
29. Chung I, Choudhury A, Patel J, Lip GY. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Ann Med 2009; 41: 45-51.
30. Yip HK, Lai SL, Lan MY, Chang WN, Liu JS, Kao YF, et al. Time course of platelet activation and von Willebrand factor in patients with non-valvular atrial fibrillation after ischemic stroke. Circ J 2007; 71: 321-326.
31. Healy AM, Hancock WW, Christie PD, Rayburn HB, Rosenberg RD. Intravascular coagulation activation in a murine model of thrombomodulin deficiency: Effects of lesion size, age, and hypoxia on fibrin deposition. Blood 1998; 92: 4188-4197.
32. Owen WG, Esmon CT. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1981; 256: 5532-5535. (Pubitemid 11035389)
33. Marayama I, Salem HH, Majerus PW. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest 1984; 74: 224-230.
34. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746.
35. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1991-1997.
36. Cacoub P, Karmochkine M, Dorent R, Nataf P, Piette JC, Godeau P, et al. Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996; 101: 160-164. (Pubitemid 26296776)
37. Jin SM, Noh CI, Bae EJ, Choi JY, Yun YS. Impaired vascular function in patients with Fontan circulation. Int J Cardiol 2007; 120: 221-226.
38. Inai K, Saita Y, Takeda S, Nakazawa M, Kimura H. Skeletal muscle hemodynamics and endothelial function in patients after Fontan operation. Am J Cardiol 2004; 93: 792-797. (Pubitemid 38338583)
39. Binotto MA, Maeda NY, Lopes AA. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation. Cardiol Young 2005; 15: 26-30.